Polymorphisms predictive of outcomes of methotrexate therapy in rheumatoid arthritis are not transferable to patients with psoriasis

Richard B. Warren; Rhodri Smith; Emanuela Campalani; Catherine Smith; Juliet N. Barker; J Worthington; Christopher Em Griffiths

Related publications

Article2009

Outcomes of methotrexate therapy for psoriasis and relationship to genetic polymorphisms

Richard B. Warren, R.L. Smith, Emanuela Campalani, Stephen Eyre, Catherine Smith, Juliet N. Barker, Jane Worthington, Christopher Em Griffiths

Article2007

The Mal/TIRAP S180L and TLR4 G299D polymorphisms are not associated with susceptibility to, or severity of, rheumatoid arthritis

Frederick J. Sheedy, Ιωάννα Μαρίνου, Luke O'neill, Anthony G. Wilson

Annals of the Rheumatic Diseases

Article2015

Methotrexate polyglutamates are associated with response to treatment in psoriasis

Catriona Maybury, Abdel Douiri, Michael Duckworth, Mónica Hernández, A.V. Anstey, David Burden, Christopher Em Griffiths, Nick J. Reynolds, Anthony D. Ormerod, Richard B. Warren, Richard Woolf, A. Marinaki, Juliet N. Barker, Catherine Smith, Bstop Study

Article2008

Genetic Variation in Efflux Transporters Influences Outcome to Methotrexate Therapy in Patients with Psoriasis

Richard B. Warren, Rhodri L. Smith, Emanuela Campalani, Stephen Eyre, Catherine Smith, Juliet N. Barker, Jane Worthington, Christopher Em Griffiths

Article1999

Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis

Zulma Ortiz, Beverley Shea, María E. Suarez‐Almazor, David Moher, George A. Wells, Peter Tugwell